Phase 2, double-blind, multicenter, randomized, placebo-controlled trial evaluating fosfomycin/tobramycin for inhalation in patients with cystic fibro
Core Function(s):
Performing Research or Evaluation
Area of Emphasis
Health-Related Activities
Target Audience:
Professionals and Para-Professionals, Children/Adolescents with Disabilities/SHCN
Unserved or Under-served Populations:
Racial or Ethnic Minorities, Disadvantaged Circumstances, Limited English, Geographic Areas
Primary Target Audience Geographic Descriptor:
Regional
COVID-19 Related Data:
N/A